IL6ST and neoplasm: The five-fold reduction in tumor volumes, the absence of small tumors around the xenograft tumors and the absence of cancer biomarker staining in the distal organs such as lungs, observed only in the sgp130 treated NOD/SCID mice, provide further evidence that sgp130 likely inhibits both the progression and metastasis of HCC.